1. Home /
  2. Drug Approvals

Drug Approvals

Should You Buy AstraZeneca After Its Positive Vaccine News?

Here's my view on this space and where the money is to be made.

Vaccine Skepticism May Hold Back Asian Recovery

Getting international travel and commerce back on track may hinge on vaccine acceptance.

An All-Terrain Strategy for Portfolio Management

The market's mood seems to be changing almost daily; he's an approach for how to trade it regardless of how it's feeling on any particular day.

Pfizer Downgraded to Hold by Our Quant Service - How Do the Charts Look?

Be careful as we could see a retest of the June low in the weeks ahead.

Eli Lilly Is Poised for a Pullback Before Renewed Longer-Term Gains

Let's review the charts and indicators.

Here Are 2 Biotech 'Chunk Plays' That Could Pick Up Nice Yardage

Amicus Therapeutics and Eiger BioPharmaceuticals set up well for using my covered call strategy.

Here Are 2 Biotechs That Posted Strong Earnings

Exelixis and Ultragenyx Pharmaceutical are cash rich mid-caps that don't look overbought.

Biotech Veru Surges Higher, Here's My Buy Strategy

VERU's cancer drug Veru-111 was found to also be effective in treating Covid-19 patients in Phase II trials.

The Game Has Dramatically Changed for Jaguar Health

JAGX has a drug that is impactful against a key symptom of Covid-19 long-hauler syndrome.

There's No Reason to Give Up on Pfizer

Why? Consistency.